The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Dec 2016 16:31

RNS Number : 0050S
Midatech Pharma PLC
15 December 2016
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

 

Midatech Pharma Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to thenotification obligation:

Legal & General (Unit Trust Managers) Limited (UTM)

Legal & General Investment Management Limited (LGIM)

 

4. Full name of shareholder(s)  (if different from 3.):

 

Legal & General Assurance Society Limited (LGAS & LGPL)

 

 

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

14 December 2016

6. Date on which issuer notified:

15 December 2016

7. Threshold(s) that is/are crossed orreached:

 

 

 

LGIM (Above 10%) UTM (Above 5%)

 

 

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

ORD GBP 0.00005

LGIM

 

 4,540,518.00

LGIM

 

 5,040,518

LGIM

 

 5,040,518

LGIM

 

10.35%

 

UTM

 

First Notification under DTR sourcebook

 

 

UTM

 

 

2,568,500

 

UTM

 

 

2,568,500

 

 

UTM

 

 

5.27%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

Expirationdate

 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

Exercise price

 

Expiration date

 

Exercise/Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 5,040,518

LGIM

 

10.35%

 

 2,568,500

UTM

 

5.27%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group) ( 5,040,518 -10.35% = Total Position)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) ( 5,040,518 - 10.35% = Total Position)

Legal & General Investment Management Limited (Indirect) (LGIM) ( 5,040,518 - 10.35% = Total Position)

Legal & General (Unit Trust Managers) Limited ( 2,568,500 - 5.27% = UTM)

Legal & General Group Plc (Direct) (L&G)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) (PMC)

Legal & General Insurance Holdings Limited (Direct) (LGIH) (LGAS & LGPL)

Legal & General Assurance (Pensions Management) Limited (PMC) (PMC)

Legal & General Assurance Society Limited (LGAS & LGPL) (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of  48,699,456

14. Contact name:

Victoria Davies (LGIM)

15. Contact telephone number:

029 2035 4147

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLTABFTMBTBBPF
Date   Source Headline
9th Jun 20208:24 amRNSForm 8.3 - Midatech Pharma plc
9th Jun 20208:10 amRNSForm 8.3 - Midatech Pharma plc
8th Jun 20207:00 amRNSResearch collaboration with Dr Reddy’s
1st Jun 202011:26 amRNSForm 8.3 - Midatech
29th May 202012:24 pmRNSForm 8.3 - Midatech Pharma plc
29th May 20209:59 amRNSHolding(s) in Company
28th May 20204:22 pmRNSForm 8.3 - Midatech Pharma Plc (Amended)
28th May 20204:00 pmRNSForm 8.3 - Midatech Pharma plc
28th May 20203:51 pmRNSForm 8.3 - [Midatech Pharma Plc]
28th May 20207:00 amRNSForm 8.3 - Midatech Pharma Plc
28th May 20207:00 amRNSForm 8.3 - Midatech Pharma Plc
27th May 20205:59 pmRNSForm 8.3 - Midatech Pharma PLC
27th May 20207:00 amRNSForm 8.3 - [Midatech Pharma plc]
26th May 20209:16 amRNSForm 8.3 - Midatech Pharma PLC
22nd May 20204:02 pmRNSForm 8.3 - Midatech Pharma plc
22nd May 20209:56 amRNSRule 2.9 Announcement
21st May 20207:01 amRNSRule 2.9 Announcement
21st May 20207:00 amRNSClosing of US$3.0m Registered Direct Offering
20th May 202011:36 amRNSForm 8.5 (EPT/RI)
19th May 202011:10 amRNSCorrection: UK Placing to Raise £1.8 million
18th May 20202:43 pmRNSUK Placing to Raise £1.8 million
18th May 20202:08 pmRNSUS$3.0 Million Registered Direct Offering
18th May 20207:00 amRNSHeadline Results for the Year Ended 31 Dec 2019
13th May 202011:28 amRNSForm 8.5 (EPT/RI)
12th May 20205:17 pmRNSAmendment to Relationship Agreement
5th May 202010:54 amRNSForm 8.3 - Midatech Pharma plc
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:28 amRNSForm 8.5 (EPT/RI)
4th May 20207:00 amRNSForm 8 (OPD) (Midatech Pharma plc)
1st May 202011:08 amRNSStatement regarding Price Movement
30th Apr 20204:42 pmRNSSecond Price Monitoring Extn
30th Apr 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20208:56 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc Replacement
22nd Apr 20203:51 pmRNSRule 2.9 Announcement - Typo Correction
22nd Apr 202012:00 pmRNSForm 8.3 - Midatech Pharma Plc - Replacement
22nd Apr 202011:43 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
21st Apr 20203:20 pmRNSForm 8.3 - Midatech Pharma plc
20th Apr 20205:22 pmRNSRule 2.9 Announcement
20th Apr 20207:00 amRNSStrategic Review Update, Formal Sale Process
31st Mar 20207:00 amRNSStrategic Review, Update and Directorate Changes
2nd Mar 20203:48 pmRNSResult of General Meeting
2nd Mar 20207:00 amRNSMidatech Expands MTX110 DIPG Programme
13th Feb 20202:05 pmRNSSecond Price Monitoring Extn
13th Feb 20202:00 pmRNSPrice Monitoring Extension
12th Feb 20202:13 pmRNSNotice of General Meeting
8th Jan 20204:41 pmRNSSecond Price Monitoring Extn
8th Jan 20204:35 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSPositive Results from MTD201-102 Study
16th Dec 20197:00 amRNSReceipt of NASDAQ Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.